Publications by authors named "Cecile Pages"

Claim this Profile
N
Neoadjuvant PD-1 and LAG-3-targeting bispecific antibody and other immune checkpoint inhibitor combinations in resectable melanoma: the randomized phase 1b/2 Morpheus-Melanoma trial.
Georgina V Long, Nitya Nair, Daniel Marbach, Richard A Scolyer, Sabine Wilson, Cecile Pages

Nat Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on dermatological toxicities of immune checkpoint inhibitors.
Davide Fattore, Giuseppe Lauletta, Cecile Pages, Valentine Theret, Vincent Sibaud

Presse Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TNF signature in advanced melanoma patients treated with immune checkpoint inhibitors: Results from the MELANFα clinical study.
Mathieu Virazels, Amélie Lusque, Stéphanie Brayer, Matthieu Genais, Carine Dufau

Int J Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Atypical and/or systemic dermatologic disorders related to immune checkpoint inhibitors: A review].
Valérian Rivet, Vincent Sibaud, Jérémie Dion, Salomé Duteurtre, Mélanie Biteau, Cécile Pages

Rev Med Interne· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant immune checkpoint inhibitors for patients with resectable stage III/IV melanoma: A nationwide real-life study in France (NEOMEL).
Charlée Nardin, Charlotte Cavalieri, Céleste Lebbé, Emilie Gérard, Marc Puyraveau, Cecile Pages

Br J Dermatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy and safety of first-line metastatic melanoma treatment with ipilimumab + nivolumab vs. nivolumab in a real-world setting.
Karine Billard, Laurent Mortier, Olivier Dereure, Sophie Dalac, Henri Montaudié, Cecile Pages

Br J Dermatol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rare Immuno-Induced Keratoacanthomas Showed on 18F-FDG PET/CT in a Metastatic Melanoma Patient.
Naia Oillarburu, Cécile Pages, Vincent Sibaud, Laurence Lamant, Marie Terroir

Clin Nucl Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International survey on training of dermatology residents in supportive oncodermatology: the RESCUE study.
Ariadna Ortiz-Brugués, Davide Fattore, Marie Boileau, Ana-Maria Forsea, Zoe Apalla

Support Care Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methods of nivolumab administration in advanced melanoma: A comparison of patients' clinical outcomes treated with flat dose or weight-adjusted dose, a multicenter observational study.
Iona Campo Le Brun, Séphane Dalle, Laurent Mortier, Olivier Dereure, Sophie Dalac Rat

Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modernizing the assessment and reporting of adverse events in oncology clinical trials using complementary statistical approaches: a case study of the MOTIVATE trial.
Mathilde Morisseau, Carlos Gomez-Roca, Marie Viala, Audrey Rabeau, Delphine Loirat, Cécile Pages

Invest New Drugs· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic value of tumor-infiltrating lymphocytes in vulvovaginal melanoma.
Margaux Vanbockstael, Guillaume Bataillon, Mathilde Morisseau, Gwenael Ferron, Justine Attal, Cécile Pages

Int J Gynecol Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
When to stop immunotherapy for advanced melanoma: the emulated target trials.
Mathilde Amiot, Laurent Mortier, Stéphane Dalle, Olivier Dereure, Sophie Dalac, Cecile Pages

EClinicalMedicine· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Dose-Rate Brachytherapy for Treatment of Facial Skin Cancers: Local Control, Toxicity, and Quality of Life in 67 Patients.
Jeanne Monge-Cadet, Benjamin Vairel, Mathilde Morisseau, Elizabeth Moyal, Anne Ducassou

Cancers (Basel)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoimmune Skin Diseases and Immune Checkpoint Inhibitors.
Davide Fattore, Luca Potestio, Lucia Genco, Cecile Pages, Ariadna Ortiz

Crit Rev Immunol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sample CME manuscript submission: Response to the article by Pham et al entitled "Review BRAF inhibition and the spectrum of granulomatous reactions".
Marion Marcaillou, Jeremie Dion, Barouyr Baroudjian, Emilien Ezrine, Cristina Carrera, Cécile Pages

J Am Acad Dermatol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intracranial Treatment in Melanoma Patients with Brain Metastasis Is Associated with Improved Survival in the Era of Immunotherapy and Anti-BRAF Therapy.
Céline Dalmasso, Cécile Pagès, Léonor Chaltiel, Vincent Sibaud, Elisabeth Moyal

Cancers (Basel)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic Treatment Initiation in Classical and Endemic Kaposi's Sarcoma: Risk Factors and Global Multi-State Modelling in a Monocentric Cohort Study.
Lina Benajiba, Jérôme Lambert, Roberta La Selva, Delphine Cochereau, Barouyr Baroudjian, Cécile Pages

Cancers (Basel)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Outcome of Neoadjuvant Tyrosine Kinase Inhibitors Followed by Complete Surgery in Locally Advanced Dermatofibrosarcoma Protuberans.
Jessica Beaziz, Maxime Battistella, Julie Delyon, Cécile Farges, Oren Marco, Cécile Pages

Cancers (Basel)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining Nivolumab and Ipilimumab with Infliximab or Certolizumab in Patients with Advanced Melanoma: First Results of a Phase Ib Clinical Trial.
Anne Montfort, Thomas Filleron, Mathieu Virazels, Carine Dufau, Jean Milhès

Clin Cancer Res· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1 inhibitors might limit the development of brain metastases in patients with advanced melanoma.
Marion Marcaillou, Clara Linder, Léonor Chaltiel, Vincent Sibaud, Cécile Pagès

Melanoma Res· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival estimation of melanoma patients with brain metastasis using the Melanoma-molGPA score: external validation from a French cohort.
Céline Dalmasso, Cécile Pagès, Léonor Chaltiel, Aurore Brun, Vincent Sibaud

Melanoma Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced Cutaneous Squamous Cell Carcinoma Is Associated with Suboptimal Initial Management in a Cohort of 109 Patients.
Florian Deilhes, Serge Boulinguez, Cécile Pagès, Carle Paul, Nicolas Meyer

Dermatology· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple Keratoacanthoma-like Lesions in a Patient Treated with Pembrolizumab.
Marion Fradet, Vincent Sibaud, Emilie Tournier, Laurence Lamant, Serge Boulinguez, Cecile Pages

Acta Derm Venereol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discoidin domain receptors: A promising target in melanoma.
Coralie Reger de Moura, Maxime Battistella, Anjum Sohail, Anne Caudron, Jean Paul Feugeas, Cecile Pages

Pigment Cell Melanoma Res· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and treatment of Kaposi's sarcoma: European consensus-based interdisciplinary guideline (EDF/EADO/EORTC).
Celeste Lebbe, Claus Garbe, Alexander J Stratigos, Catherine Harwood, Ketty Peris, Cecile Pages

Eur J Cancer· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis